HSE CEO Paul Reid
HSE CEO Paul Reid said the total vaccination programme this week will be between 310,000 and 330,000 and of that 90,000 shots will be AstraZeneca.
Following on from that, he said, around 100,000 AstraZeneca vaccines should be administered.
He said the HSE gets confirmation of delivery around two weeks ahead of each vaccine supply line, adding there are very strong supply lines for the next two weeks, and after that the HSE will deal primarily with Pfizer and Moderna.
AstraZeneca´s Covid vaccine, which was developed with the University of Oxford, faces fresh safety doubts.
The AstraZeneca jab has been suspended in several European countries over reports of rare blood clots.
A top official in the European Medicines Agency was on Sunday reported as having suggested that it might be worth abandoning AstraZeneca´s vaccine if alternatives were available.
But the EMA said the body’s head of vaccine strategy, Marco Cavaleri, had been misrepresented, and that he believed its benefits outweigh its risks.
“The decision on its use in different populations and ages is the prerogative of the EU Member States, based on specific factors such as virus circulation and vaccine availability,” a spokeswoman said.